Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Eptacog Alfa · Sevenfact

Recombinant protein · Protein replacement: Tissue factor (F3) · developed by Laboratoire Franais Du Fractionnement Et Des Biotechnologies Socit Anonyme

Approved FDA
2 Registered trials

What is Eptacog Alfa?

Eptacog alfa is a recombinant analog of human coagulation factor VIIa. Complexed with tissue factor, it activates factor X to factor Xa, bypassing factor VIII and factor IX, to form a hemostatic clot at sites of bleeding. It is used to treat bleeding episodes in hemophilia with inhibitors and is being studied in intracerebral hemorrhage.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Sevenfact, Recombinant Factor VIIa, rFVIIa
Drug type
Recombinant protein
Targets
Tissue factor (F3) (binding partner it blocks), Coagulation factor X (F10) (secondary target)
Mechanism
Protein replacement: Tissue factor (F3)
Pathways
coagulation cascade, common pathway of coagulation, thrombin generation, fibrin clot formation
Therapy area
Hematology
Developer
Laboratoire Franais Du Fractionnement Et Des Biotechnologies Socit Anonyme
In trials of
NVO, TAK
FDA status
Approved as Sevenfact, BLA125641 · FDA label
UNII
AC71R787OV

✅ FDA-approved uses

From the indications section of the FDA label (version of Nov 19, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04563520 Phase 3 Hemophilia A Withdrawn TAK
NCT07227246 Phase 3 Intracerebral Hemorrhage Recruiting NVO

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Intracerebral HemorrhageHemophilia A

Other drugs acting on F3

Sources

Updated Nov 15, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.